'Azithromycin before Birth'- Single dose azithromycin shortly before birth to reduce infection in Aboriginal mothers and babies: a randomised controlled trial.
'Azithromycin before Birth'- Single dose azithromycin shortly before birth to reduce infection in Aboriginal mothers and babies: a randomised controlled trial.
“出生前服用阿奇霉素”——在出生前不久服用单剂量阿奇霉素以减少原住民母亲和婴儿的感染：一项随机对照试验。
批准号：
nhmrc : 2001751
负责人：
金额：
$320.51万
依托单位国家：
澳大利亚
项目类别：
Clinical Trials and Cohort Studies Grants
财政年份：
2021
资助国家：
澳大利亚
项目状态：
未结题
起止时间：
2021-01-01 至 2026-12-31
中文摘要
翻译
北领地的土著母亲和婴儿的感染率很高。在分娩期间(或在剖腹产前)单剂阿奇霉素可能会降低随后的细菌感染率。这项务实的临床试验(‘产前阿奇霉素’)将评估一种简单的干预措施，它有可能显著改善出生后有新细菌感染风险的妇女和婴儿的健康结果。
英文摘要
Aboriginal mothers and babies in the Northern Territory have high rates of infection. A single dose of azithromycin given during labour (or prior to caesarean section) may reduce the rates of subsequent bacterial infection. This pragmatic clinical trial ('Azithromycin before Birth') will assess a simple intervention that has the potential to substantially improve health outcomes for women and babies at risk of new bacterial infection after birth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
